发明公开
EP3069722A1 REGULATION OF IMMUNE RESPONSES BY MANIPULATION OF INTERMEDIARY METABOLITE LEVELS
审中-公开

基本信息:
- 专利标题: REGULATION OF IMMUNE RESPONSES BY MANIPULATION OF INTERMEDIARY METABOLITE LEVELS
- 专利标题(中):REGULIERUNG DER IMMUNANTWIT MITTELS MANIPULATION DES ZWISCHENMETABOLITGEHALTES
- 申请号:EP16164633.6 申请日:2004-02-27
- 公开(公告)号:EP3069722A1 公开(公告)日:2016-09-21
- 发明人: ILAN, Yaron , ENGELHARDT, Dean L. , ZIMRAN, Ari , MARGALIT, Maya , RABBANI, Elazar
- 申请人: ENZO THERAPEUTICS, INC.
- 申请人地址: 60 Executive Boulevard Farmingdale, New York 11735-4716 US
- 专利权人: ENZO THERAPEUTICS, INC.
- 当前专利权人: ENZO THERAPEUTICS, INC.
- 当前专利权人地址: 60 Executive Boulevard Farmingdale, New York 11735-4716 US
- 代理机构: Vossius & Partner Patentanwälte Rechtsanwälte mbB
- 优先权: US375906 20030227
- 主分类号: A61K31/7032
- IPC分类号: A61K31/7032 ; A61K35/12 ; A61K38/17 ; A61P35/00 ; A61P31/00 ; A61P37/02 ; A61K38/00 ; A61K31/00 ; A61K31/7004 ; A61K31/7028 ; A61K35/15 ; A61K35/17
摘要:
The present invention provides novel processes for regulating immune responses in mammalian subjects, e.g., humans, afflicted with diseases such as cancers, infections, e.g., viral infections, bacterial infections, or immune dysfunctions, especially auto-immune disorders, e.g., diabetes, Crohn's disease, rheumatoid arthritis, arteriosclerosis and ulcerative colitis. More particularly, this invention relates to generating elevated levels of an intermediary metabolite, e.g., lipids or conjugated biomolecules, e.g., glycolipids, lipoproteins and glycoproteins other than antibodies, cytokines or hormones. Treatment can be carried by introduction of the intermediary metabolite into the afflicted subject or by a reagent that when administered leads to elevated levels. The treatment regimen can be in vivo or ex vivo.
摘要(中):
本发明提供了用于调节哺乳动物受试者(例如,患有诸如癌症,感染例如病毒感染,细菌感染或免疫功能障碍,尤其是自身免疫性疾病,例如糖尿病,Crohn's 疾病,类风湿性关节炎,动脉硬化和溃疡性结肠炎。 更具体地说,本发明涉及产生高水平的中间代谢产物,例如除抗体,细胞因子或激素之外的脂质或共轭生物分子,例如糖脂,脂蛋白和糖蛋白。 可以通过将中间体代谢物引入受影响的受试者或当施用导致升高的水平的试剂时进行治疗。 治疗方案可以在体内或体外。
IPC结构图谱:
A | 人类生活必需 |
--A61 | 医学或兽医学;卫生学 |
----A61K | 医用、牙科用或梳妆用的配制品 |
------A61K31/00 | 含有机有效成分的医药配制品 |
--------A61K31/70 | .碳水化合物;糖;其衍生物 |
----------A61K31/7028 | ..含有通过配糖键与非糖化合物连接的糖基的化合物 |
------------A61K31/7032 | ...与多元醇连接,即含有两个或3个游离或者酯化的羟基的化合物,例如葡萄糖基—二酰基甘油酯、乳糖酸、神经节苷脂 |